Davidorf F H
Surv Ophthalmol. 1981 May-Jun;25(6):373-7. doi: 10.1016/0039-6257(81)90073-4.
Controversy exists regarding the management of patients with choroidal melanomas. Some experts argue that these neoplasms behave differently than other types of melanomas, and that enucleation rather than tumor burden is responsible for metastases. A review of the literature involving death rates of patients diagnosed with melanomas of the choroid, skin and iris demonstrates the importance of tumor volume as a prognostic indicator. In each instance, the smaller the tumor burden, the better the prognosis. Death rates from metastases involving small choroidal tumors (less than 300 mm) were surprisingly similar to to those from cutaneous melanomas of the same size. Large tumors of the choroid carried a much higher death rate, as did large tumors of the skin. While studies involving iris melanomas reported only a 2.6% death rate, the average volume of an iris melanoma is only 55 mm. We believe that biologically all melanomas have the same potential for metastatic growth and that the size of the tumor may be the most important variable with regard to prognosis.
关于脉络膜黑色素瘤患者的治疗存在争议。一些专家认为,这些肿瘤的行为与其他类型的黑色素瘤不同,转移是由眼球摘除而非肿瘤负荷导致的。一项涉及脉络膜、皮肤和虹膜黑色素瘤患者死亡率的文献综述表明,肿瘤体积作为预后指标的重要性。在每种情况下,肿瘤负荷越小,预后越好。小脉络膜肿瘤(小于300立方毫米)转移导致的死亡率与相同大小的皮肤黑色素瘤惊人地相似。大脉络膜肿瘤的死亡率要高得多,皮肤大肿瘤也是如此。虽然涉及虹膜黑色素瘤的研究报告的死亡率仅为2.6%,但虹膜黑色素瘤的平均体积仅为55立方毫米。我们认为,从生物学角度来看,所有黑色素瘤都有相同的转移生长潜力,就预后而言,肿瘤大小可能是最重要的变量。